Research Webinars, • 8/6/24 An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD Previous Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML Next Interface guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS You Might Also Like Neoplasias Hematológicas Hereditarias: No Tan Poco Frecuentes (September 2024) Module 1 - Seeds, Weeds and RUNX1-FPD: Understanding Blood Cancer Development Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML RRP Patient Meeting 2023: NIH RUNX1 Clinical Study Update - Dr. David Young Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study
Research Webinars, • 8/6/24 An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD Previous Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML Next Interface guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS You Might Also Like Neoplasias Hematológicas Hereditarias: No Tan Poco Frecuentes (September 2024) Module 1 - Seeds, Weeds and RUNX1-FPD: Understanding Blood Cancer Development Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML RRP Patient Meeting 2023: NIH RUNX1 Clinical Study Update - Dr. David Young Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study
